Full-Time

Billing Strategy Lead

Posted on 11/19/2024

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions

Biotechnology
Healthcare

Compensation Overview

$114.4k - $143kAnnually

Senior, Expert

Remote in USA

Category
Project Management
Strategy Development
Business Development
Business & Strategy
Required Skills
Power BI
SQL
Business Analytics
Data Analysis
Excel/Numbers/Sheets
Requirements
  • Bachelor's Degree in business, economics, related field, or equivalent required.
  • Minimum of 8 years of experience in business administration, information systems, health sciences, insurance company, or healthcare billing organization.
  • Advanced proficiency with quantitative software programs (Microsoft Excel, Google Sheets).
  • Basic SQL knowledge and ability to query databases.
  • Experience with BI tools (e.g., Business Objects, Hyperion) preferred.
Responsibilities
  • Conduct complex data analysis and interpretation to support decision-making by organizational stakeholders.
  • Provide timely financial and business analytics, including monitoring and reporting on key performance indicators.
  • Analyze payer contract compliance, prior authorization, denial, and reimbursement trends.
  • Conduct in-depth reviews and audits to identify issues/trends and develop actionable remediation plans.
  • Design, execute, and evaluate improvement projects based on data-driven insights.
  • Develop actionable roadmaps for improving workflows and processes.
  • Coordinate with multiple teams for process improvement and efficiency optimization.
  • Monitor adherence to SOPs, SLAs, productivity, and quality standards set by leadership.
  • Support project management to ensure successful and timely completion.
  • Assist with governance and rollout of Natera SOP documentation.
  • Utilize tools such as Excel, Power BI, and other business intelligence tools for a wide range of analytics functions.
  • Comply with HIPAA/PHI privacy regulations when handling PHI and complete required training within 30 days of hire.

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care through precise genetic insights.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

8%

1 year growth

24%

2 year growth

61%
Simplify Jobs

Simplify's Take

What believers are saying

  • Natera's continuous innovation, such as the launch of the Prospera Heart test with DQS, demonstrates its commitment to improving patient outcomes and maintaining market leadership.
  • The company's diverse product offerings across oncology, transplant health, and women's health provide multiple revenue streams and reduce dependency on a single market.
  • Significant investments from entities like Massachusetts Financial Services Co. MA indicate strong financial backing and confidence in Natera's growth potential.

What critics are saying

  • Allegations of deceptive sales and billing practices could damage Natera's reputation and lead to legal and financial repercussions.
  • The highly competitive nature of the genetic testing market requires constant innovation and differentiation to maintain market share.

What makes Natera unique

  • Natera's focus on cell-free DNA (cfDNA) technology for a wide range of applications, from oncology to prenatal screening, sets it apart from competitors who may specialize in only one area.
  • The introduction of unique features like the Donor Quantity Score (DQS) for transplant rejection detection enhances the accuracy and reliability of their tests, distinguishing them from other genetic testing companies.
  • Natera's extensive portfolio of over 200 peer-reviewed publications underscores its commitment to scientific validation and credibility, which is a significant competitive advantage.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks